Adding Lisinopril to Patient's Regimen
Yes, lisinopril can be added to the patient's regimen as ACE inhibitors are recommended first-line therapy for patients with heart failure with reduced ejection fraction (HFrEF) and have been shown to reduce mortality and hospitalizations. 1
Benefits of Adding Lisinopril
ACE inhibitors have conclusively demonstrated significant benefits in heart failure:
Lisinopril specifically:
Dosing Recommendations
- Start with a low dose: 2.5-5.0 mg once daily 1
- Gradually titrate dose at intervals of not less than 2 weeks 1
- Target dose: 30-35 mg once daily, or highest tolerated dose 1
- Remember that some ACE inhibitor is better than no ACE inhibitor 1
Monitoring Requirements
- Check blood chemistry (urea, creatinine, potassium) and blood pressure within 1-2 weeks of initiation 1
- Continue periodic monitoring, especially in patients with:
- Pre-existing hypotension
- Hyponatremia
- Diabetes mellitus
- Azotemia
- Those taking potassium supplements 1
Potential Adverse Effects to Watch For
Hypotension
- More common in patients with:
- Management: Consider reducing diuretic dose if no signs of congestion 1
Renal Function Changes
- Small increases in creatinine are expected and often don't require intervention 1
- More significant if:
Hyperkalemia
- Risk increases with:
Cough
- Common side effect but rarely requires discontinuation 1
- Important to differentiate from pulmonary edema 1
- If troublesome, consider ARB substitution 1
Contraindications
- History of angioedema with previous ACE inhibitor use 4
- Pregnancy (Category D) 4
- Avoid co-administration with aliskiren in patients with diabetes 4
Special Considerations
If patient is on diuretics:
- Consider decreasing or discontinuing diuretic temporarily
- Increase salt intake prior to starting lisinopril
- If neither is possible, start with lower dose of lisinopril 4
For patients with renal impairment:
Drug interactions to monitor:
By following these recommendations, lisinopril can be safely and effectively added to the patient's regimen to improve outcomes in heart failure management.